Found: 5
Select item for more details and to access through your institution.
The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.
- Published in:
- Gene Therapy, 2008, v. 15, n. 7, p. 495, doi. 10.1038/gt.2008.7
- By:
- Publication type:
- Article
p21<sup>(WAF1)</sup>-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy.
- Published in:
- Gene Therapy, 2007, v. 14, n. 3, p. 246, doi. 10.1038/sj.gt.3302871
- By:
- Publication type:
- Article
Identification of RBCK1 as a novel regulator of FKBPL: implications for tumor growth and response to tamoxifen.
- Published in:
- Oncogene, 2014, v. 33, n. 26, p. 3441, doi. 10.1038/onc.2013.306
- By:
- Publication type:
- Article
Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.
- Published in:
- Cancer Gene Therapy, 2006, v. 13, n. 6, p. 598, doi. 10.1038/sj.cgt.7700933
- By:
- Publication type:
- Article
The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate?
- Published in:
- Journal of Gene Medicine, 2008, v. 10, n. 9, p. 1032, doi. 10.1002/jgm.1221
- By:
- Publication type:
- Article